Krsnaa Diagnostics gets approval for 16.21 lakh warrants to Promoters at Rs 566

Fund Raising View source PDF Explain this filing

KRSNAA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹534.00

prior close

₹531.55

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-0.5% vs market

Healthcare Service Provider peers, median of 27sector+0.0%-0.3% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.3 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.0

10m

+0.2

15m

+0.5

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3+0.3-0.5+0.0-0.3

Next day

-0.6+1.1-1.7+0.3-0.9

-0.3+1.3-1.6-0.7+0.3

-1.5+2.0-3.5+2.1-3.5

+0.6+0.3+0.2-0.7+1.2

+0.1+1.1-0.9-1.2+1.3

-3.6-3.2-0.4-0.4-3.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Krsnaa Diagnostics has received in-principle approval from BSE and NSE to issue 16,21,000 convertible warrants to the Promoter and Promoter Group on a preferential basis. Each warrant is convertible into one equity share of face value Rs. 5 at an issue price of Rs. 566 per warrant, taking the total deal size to around Rs. 91.75 crore. The allotment is being done under Regulation 28(1) of SEBI LODR.

Likely market impact

Promoter group strengthening its stake signals confidence in the company, but conversion of warrants will lead to equity dilution for existing shareholders.